Shortage of critical children’s cancer drug causes concerns nationwide

The FDA declared a shortage of Vincristine, an essential drug for thousands of children with cancer across the country. It’s now only made by one company after Teva Pharmaceuticals ended production in July. Doctors say the shortage exposes a larger problem as parents push to get the life-saving treatment for their kids.Oct. 18, 2019